Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 4, 2010, Pages 237-244

  Lund, T ^a   Mangsbo, S M ^b   Scholz, H ^a   Gjorstrup, P ^c   Ttterman, T H ^b   Korsgren, O ^b   Foss, A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c Resolvyx Pharmaceuticals   (United States)

Author keywords

Cytokine; IBMIR; Islet; Resolvin; Transplantation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIINFLAMMATORY AGENT; CYTOKINE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1; RESOLVIN E1; THROMBOPLASTIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD GROUP ABO SYSTEM; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN RELEASE; PANCREAS ISLET; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; APOPTOSIS; BIOLOGICAL MARKERS; CELL SURVIVAL; CYTOKINES; EICOSAPENTAENOIC ACID; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; ISLETS OF LANGERHANS; ORGAN CULTURE TECHNIQUES; RECEPTORS, LEUKOTRIENE B4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOPLASTIN;

EID: 77951034707     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1241825     Document Type: Article

References (47)

1. Arita M, Bianchini F, Aliberti J, etal. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005 201 713-722
2. Arita M, Ohira T, Sun YP, etal. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007 178 3912-3917
3. Arita M, Yoshida M, Hong S, etal. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA 2005 102 7671-7676
4. Bannenberg G, Moussignac RL, Gronert K, etal. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br J Pharmacol 2004 143 43-52
5. Bannenberg GL, Chiang N, Ariel A, etal. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 2005 174 4345-4355
6. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005 77 587-597
7. Bennet W, Sundberg B, Groth CG, etal. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999 48 1907-1914
8. Bradbury DA, Simmons TD, Slater KJ, etal. Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis. J Immunol Methods 2000 240 79-92
9. Campbell EL, Louis NA, Tomassetti SE, etal. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J 2007 21 3162-3170
10. Dona M, Fredman G, Schwab JM, etal. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 2008 112 848-855
11. Eich T, Eriksson O, Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007 356 2754-2755 (Pubitemid 47001066)
12. Eich T, Eriksson O, Sundin A, etal. Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 2007 84 893-898
13. Goto M, Eich TM, Felldin M, etal. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004 78 1367-1375
14. Goto M, Holgersson J, Kumagai-Braesch M, etal. The ADP/ATP ratio: A novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant 2006 6 2483-2487
15. Heit JJ, Apelqvist AA, Gu X, etal. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 2006 443 345-349
16. Herrera BS, Ohira T, Gao L, etal. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol 2008 155 1214-1223
17. Hjelmesaeth J, Hagen LT, Asberg A, etal. The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol Dial Transplant 2007 22 1743-1749
18. Johansson H, Lukinius A, Moberg L, etal. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005 54 1755-1762
19. Johansson U, Olsson A, Gabrielsson S, etal. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 2003 308 474-479
20. Johnson JD, Ao Z, Ao P, etal. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant 2009 in press
21. Kim JH, Park SG, Lee HN, etal. ATP measurement predicts porcine islet transplantation outcome in nude mice. Transplantation 2009 87 166-169
22. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008 8 279-289
23. Kurt-Jones EA, Popova L, Kwinn L, etal. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000 1 398-401
24. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996 20 463-466
25. Lewis EC, Mizrahi M, Toledano M, etal. Alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci U S A 2008 105 16236-16241
26. Lund T, Fosby B, Korsgren O, etal. Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transpl Int 2008 21 669-678
27. Marzorati S, Melzi R, Nano R, etal. In vitro modulation of monocyte chemoattractant protein-1 release in human pancreatic islets. Transplant Proc 2004 36 607-608 (Pubitemid 38534338)
28. Mita A, Ricordi C, Miki A, etal. Anti-proinflammatory effects of sirolimus on human islet preparations. Transplantation 2008 86 46-53
29. Moberg L, Johansson H, Lukinius A, etal. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002 360 2039-2045
30. Moberg L, Olsson A, Berne C, etal. Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation 2003 76 1285-1288
31. Paraskevas S, Maysinger D, Wang R, etal. Cell loss in isolated human islets occurs by apoptosis. Pancreas 2000 20 270-276
32. Piemonti L, Leone BE, Nano R, etal. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002 51 55-65
33. Rhode A, Pauza ME, Barral AM, etal. Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. J Immunol 2005 175 3516-3524
34. Ruth MR, Proctor SD, Field CJ. Effects of feeding fish oil on mesenteric lymph node cytokine responses in obese leptin receptor-deficient JCR:LA-cp rats. Int J Obes (Lond) 2009 33 96-103
35. Samuelsson B, Dahlen SE, Lindgren JA, etal. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987 237 1171-1176
36. Schroppel B, Zhang N, Chen P, etal. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways. J Am Soc Nephrol 2004 15 1853-1861
37. Schulthess FT, Paroni F, Sauter NS, etal. CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab 2009 9 125-139
38. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002 68-69 433-455
39. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007 25 101-137
40. Serhan CN, Clish CB, Brannon J, etal. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000 192 1197-1204
41. Serhan CN, Hong S, Gronert K, etal. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002 196 1025-1037
42. Serhan CN, Yang R, Martinod K, etal. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 2009 206 15-23
43. Shapiro AM, Gallant HL, Hao EG, etal. The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit 2005 27 35-37
44. Shapiro AM, Ricordi C, Hering BJ, etal. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006 355 1318-1330
45. Steer SA, Scarim AL, Chambers KT, etal. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med 2006 3 e17
46. Vassiliou EK, Kesler OM, Tadros JH, etal. Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells. J Immunol 2008 181 4534-4544
47. Yokomizo T, Izumi T, Chang K, etal. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 1997 387 620-624